Tumor necrosis factor inhibits conversion of dehydroepiandrosterone sulfate (DHEAS) to DHEA in rheumatoid arthritis synovial cells: A prerequisite for local androgen deficiency
Open Access
- 2 June 2005
- journal article
- research article
- Published by Wiley in Arthritis & Rheumatism
- Vol. 52 (6) , 1721-1729
- https://doi.org/10.1002/art.21112
Abstract
Objective Use of anti–tumor necrosis factor (anti-TNF) antibody therapy in rheumatoid arthritis (RA) has expanded our understanding of possible mechanisms by which this treatment reduces inflammation. Beyond its effects on local immune responses, anti-TNF treatment may also modulate the local hormone supply. Because androgens are thought to inhibit immune responses, their presence in inflamed tissue is an additional important antiinflammatory factor. Methods We investigated conversion of the ubiquitous dehydroepiandrosterone sulfate (DHEAS), the biologically inactive precursor of DHEA, to the androgen DHEA in mixed synovial cells from patients with RA and patients with osteoarthritis (OA), making use of thin-layer chromatography and phosphorimaging. Using immunohistochemical analysis, we detected the key enzyme, steroid sulfatase. Results DHEAS-to-DHEA conversion in synovial cells from patients with RA was significantly lower than that in synovial cells from patients with OA (mean ± SEM 3.3 ± 0.5% versus 6.0 ± 0.9% of applied 3H-DHEAS per 106 synovial cells; P = 0.042). In RA, but not in OA, the level of converted 3H-DHEA was inversely correlated with the density of synovial macrophages (for RA, Rrank = −0.725, P = 0.005; for OA, Rrank = 0.069, P not significant [NS]) and T cells (for RA, Rrank = −0.621, P = 0.024; for OA, Rrank = 0.247, P NS). Double immunohistochemistry analysis revealed that steroid sulfatase was located mainly in synovial macrophages but was also observed in fibroblasts. Neutralization of TNF largely up-regulated the conversion of DHEAS to DHEA in RA, but not in OA. A similar neutralizing effect was observed with polyclonal human immunoglobulins; this effect is most probably mediated via TNF neutralization at low TNF concentrations. Conclusion These data indicate that TNF inhibits the conversion of DHEAS to DHEA in RA synovial cells. Because androgens are antiinflammatory mediators, TNF-induced inhibition of the local androgen supply is a supplementary proinflammatory factor. Consequently, anti-TNF strategies may also exert their positive effects by increasing tissue androgens.Keywords
This publication has 32 references indexed in Scilit:
- Long‐term anti–tumor necrosis factor antibody therapy in rheumatoid arthritis patients sensitizes the pituitary gland and favors adrenal androgen secretionArthritis & Rheumatism, 2003
- The loss of sympathetic nerve fibers in the synovial tissue of patients with rheumatoid arthritis is accompanied by increased norepinephrine release from synovial macrophagesThe FASEB Journal, 2000
- Adrenocorticotropin, Glucocorticoid, and Androgen Secretion in Patients with New Onset Synovitis/Rheumatoid Arthritis: Relations with Indices of InflammationJournal of Clinical Endocrinology & Metabolism, 2000
- Androgens as adjuvant treatment in postmenopausal female patients with rheumatoid arthritis.Annals of the Rheumatic Diseases, 1996
- Treatment of Crohn's disease with anti-tumor necrosis factor chimeric monoclonal antibody (cA2)Gastroenterology, 1995
- Regulation of macrophage dehydroepiandrosterone sulfate metabolism by inflammatory cytokinesEndocrinology, 1994
- Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor αArthritis & Rheumatism, 1993
- Sex hormone status and osteoporosis in postmenopausal women with rheumatoid arthritisArthritis & Rheumatism, 1988
- The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritisArthritis & Rheumatism, 1988
- Plasma Dehydroepiandrosterone, Dehydroepiandrosterone Sulphate and Androsterone Sulphate Levels and Their Interaction with Plasma Proteins in Rheumatoid ArthritisExperimental and Clinical Endocrinology & Diabetes, 1984